AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Matglim 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

JV Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Matglim 1mg/500mg Tablet SR

DiaGlym SR, a 1mg/500mg combination tablet, combats type 2 diabetes in adults. This antidiabetic medication effectively manages blood glucose levels by combining two active agents. Always ingest DiaGlym SR with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, DiaGlym SR complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Commonly, DiaGlym SR can cause hypoglycemia (low blood sugar). Learn to identify symptoms like sweating, dizziness, headache, and trembling, and know how to treat them. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. DiaGlym SR is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding women must consult their doctor prior to use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.

Primary Ingredients of Matglim 1mg/500mg Tablet SR

No text was provided to rewrite.

Uses of Matglim 1mg/500mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Matglim 1mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. The Matglim 1mg/500mg sustained-release tablet should be taken with meals.

Common Side effects of Matglim 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Matglim 1mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or breaking it. The Matglim 1mg/500mg sustained-release tablet should be taken with a meal.

How Matglim 1mg/500mg Tablet SR works:

Each Matglim 1mg/500mg sustained-release tablet combines glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts threefold: it decreases hepatic glucose production, slows intestinal glucose uptake, and enhances insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Matglim 1mg/500mg SR tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Matglim 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Matglim tablets (1mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when prescribing Matglim 1mg/500mg SR tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician before administration. Matglim 1mg/500mg SR tablets are contraindicated in patients exhibiting severe renal impairment. Close monitoring of renal function is recommended throughout the treatment period.

LiverLiverCAUTION

Exercise caution when prescribing Matglim 1mg/500mg Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. For patients exhibiting mild to moderate liver disease, initiate Matglim 1mg/500mg Tablet SR therapy at a reduced dosage; its use is contraindicated in those with severe liver dysfunction.

What if you forget to take Matglim 1mg/500mg Tablet SR :

Should you forget a Matglim 1mg/500mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Matglim 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Matglim 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Matglim 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA – Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Matglim 1mg/500mg Tablet SR and seek immediate medical attention.
Matglim 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Matglim 1mg/500mg Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Matglim 1mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Matglim 1mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Matglim 1mg/500mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Matglim 1mg/500mg Tablet ...
35
MRP 40
13% off